| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 41 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $189.36M | - | |
| CEO | 214.5K | $130.85M | - | |
| VP | 47.8K | $29.18M | - | |
| VP | 29.5K | $18.00M | - | |
| VP | 21.7K | $13.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Zoghbi Huda Y | Director | Sale+OE | 1,117 | $900.00 | $1,005,300.00 | -47.3% | +7.1% | -21.0% | |
| Jan 2, 2024 | Yancopoulos George50 | Bd. Co-chair, President &CSO | Sell | 16,848 | $900.00 | $15,163,200.00 | -8.6% | +7.1% | -21.0% | |
| Jan 2, 2024 | McCourt Marion55 | EVP Commercial | Sell | 274 | $873.91 | $239,451.34 | -1.8% | +7.1% | -21.0% | |
| Dec 27, 2023 | Brown Michael S49 | Director | Sale+OE | 2,049 | $898.00 | $1,840,002.00 | -62.2% | +10.2% | -18.0% | |
| Dec 27, 2023 | Fenimore Christopher R.66 | SVP Controller | Sell | 2,448 | $856.71 | $2,097,226.08 | -14.6% | +10.2% | -18.0% | |
| Dec 22, 2023 | Fenimore Christopher R.66 | SVP Controller | Sell | 1,930 | $844.30 | $1,629,501.90 | -3.6% | +14.3% | -17.1% | |
| Dec 13, 2023 | Bassler Bonnie L59 | Director | Sale+OE | 610 | $870.00 | $530,700.00 | -32.8% | +10.8% | -15.4% | |
| Dec 11, 2023 | McCourt Marion55 | EVP Commercial | Sell | 270 | $838.44 | $226,378.80 | -1.3% | +13.7% | -8.2% | |
| Dec 5, 2023 | Murphy Andrew J54 | EVP Research | Sale+OE | 6,536 | $817.44 | $5,342,787.40 | -0.9% | +18.3% | -8.1% | |
| Dec 1, 2023 | Ryan Arthur F54 | Director | Sell | 100 | $817.30 | $81,729.89 | - | +18.6% | -7.9% |